Considerations For Pre-Operative Therapy To Optimize Care Of Women With Her2+ Breast Cancer

Considerations for Pre-operative Therapy to Optimize Care of Women with HER2+ Breast Cancer

Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani

Total Health | Oncology

Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo

Total Health | Oncology

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. Schwartzberg

Total Health | Oncology

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Meisel & Dr. Soliman

Total Health | Oncology

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Irene and Dr. Vogel

Total Health | Oncology

Optimizing treatment in patients with early-stage HER2-positive breast cancer

HER2+ Early-Stage Breast Cancer: Peri-Operative Therapy

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Kaklamani and Dr. O’Regan

Total Health | Oncology

Advanced Breast Cancer: Challenges in Pathways Development

Optimizing Therapy in HER2+ Disease with Dr. Kevin Kalinsky

Total Health | Oncology

Leveraging Targeted Therapies to Improve Outcomes Across the Continuum of HER2+ Breast Cancer

PeerView Oncology

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Bagegni & Dr. Gradishar

Total Health | Oncology

Adjuvant Therapy | 2023 Best of Breast Conference

Total Health | Oncology

HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches

ASCP

HER2+ Early-Stage Breast Cancer: Neoadjuvant Strategies

Targeted Oncology

Overview of Neoadjuvant Therapy in HER2+ Breast Cancer

A presurgery combination therapy may improve outcomes for women with HER2 positive breast cancer

Dr. Pegram on Neoadjuvant Treatments for HER2-Postive Breast Cancer